Radiation/Chemoradiation in Treatment of Carcinoma of the Larynx

  • Bidhu K. Mohanti


The larynx is, both anatomically and physiologically, an exquisite human organ. It performs the unique function of phonation and speech. Our deglutition is also intimately synchronized with the laryngeal mobility.


  1. 1.
    Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67:31–50.CrossRefGoogle Scholar
  2. 2.
    D’Souza L, Jaswal J, Chan F, Johnson M, Tay KY, Fung K, Palma D. Evaluating the impact of an integrated multidisciplinary head & neck competency-based anatomy & radiology teaching approach in radiation oncology: a prospective cohort study. BMC Med Educ. 2014;14:124.CrossRefGoogle Scholar
  3. 3.
    Cocek A. The history and current status of surgery in the treatment of laryngeal cancer. Acta Med (Hradec Kralove). 2008;51:157–63.CrossRefGoogle Scholar
  4. 4.
    Finzi N. Untitled letter to Lancet. Lancet. 1909;1:868.CrossRefGoogle Scholar
  5. 5.
    Lederman M. History of radiotherapy in the treatment of cancer of the larynx, 1896–1939. Laryngoscope. 1975;85:333–53.CrossRefGoogle Scholar
  6. 6.
    Fletcher GH. History of irradiation in squamous cell carcinomas of the larynx and hypopharynx. Int J Radiat Oncol Biol Phys. 1986;12:2019–24.CrossRefGoogle Scholar
  7. 7.
    Garland LH. Cancer of the larynx; results of surgical and radiological treatment in one institution. Calif Med. 1966;105:8–10.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Genden EM, Ferlito A, Silver CE, Jacobson AS, Werner JA, Suárez C, Leemans CR, Bradley PJ, Rinaldo A. Evolution of the management of laryngeal cancer. Oral Oncol. 2007;43:431–9.CrossRefGoogle Scholar
  9. 9.
    Glick JH, Zehngebot LM, Taylor SG 4th. Chemotherapy for squamous cell carcinoma of the head and neck: a progress report. Am J Otolaryngol. 1980;1:306–23.CrossRefGoogle Scholar
  10. 10.
    Norris CM Jr, Clark JR, Frei E, Ervin TJ, Fallon B, Tuttle SA, Fabian RL, Miller D. Pathology of surgery after induction chemotherapy: an analysis of resectability and locoregional control. Laryngoscope. 1986;96:292–302.CrossRefGoogle Scholar
  11. 11.
    Demard F, Chauvel P, Santini J, Vallicioni J, Thyss A, Schneider M. Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck. 1990;12:225–31.CrossRefGoogle Scholar
  12. 12.
    Robertson AG, Robertson C, Boyle P, Symonds RP, Wheldon TE. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer. 1993;29A(4):501–10.CrossRefGoogle Scholar
  13. 13.
    Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;39:115–26.CrossRefGoogle Scholar
  14. 14.
    Overgaard J, Mohanti BK, Begum N, Ali R, Agarwal JP, Kuddu M, Bhasker S, Tatsuzaki H, Grau C. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. Lancet Oncol. 2010;11:553–60.CrossRefGoogle Scholar
  15. 15.
    Mohanti BK, Tandon DA, Bahadur S, Rath GK, Tanwar RK, Lal P, Biswal BM. Results of definitive radiotherapy in T1 and T2 glottic carcinoma: Institute of Rotary Cancer Hospital experience. Australas Radiol. 1996;40:287–90.CrossRefGoogle Scholar
  16. 16.
    Stokes WA, Abbott D, Phan A, Raben D, Lanning RM, Karam SD. Patterns of care for patients with early-stage glottic cancer undergoing definitive radiation therapy: a national cancer database analysis. Int J Radiat Oncol Biol Phys. 2017;98:1014–21.CrossRefGoogle Scholar
  17. 17.
    Aaltonen LM, Rautiainen N, Sellman J, Saarilahti K, Mäkitie A, Rihkanen H, Laranne J, Kleemola L, Wigren T, Sala E, Lindholm P, Grenman R, Joensuu H. Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy. Int J Radiat Oncol Biol Phys. 2014;90:255–60.CrossRefGoogle Scholar
  18. 18.
    Warner L, Chudasama J, Kelly CG, Loughran S, McKenzie K, Wight R, Dey P. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev. 2014;12:CD002027. Scholar
  19. 19.
    Thakar A, Bahadur S, Mohanti BK, Nivsarkar S. Clinically staged T3N0M0 laryngeal cancer: how is it best treated? Definitive radiotherapy with salvage surgery v/s combined surgery and radiotherapy. J Laryngol Otol. 2000;114:108–12.CrossRefGoogle Scholar
  20. 20.
    The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.CrossRefGoogle Scholar
  21. 21.
    Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol. 2013;31:853–9.CrossRefGoogle Scholar
  22. 22.
    Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31:845–52.CrossRefGoogle Scholar
  23. 23.
    Grover S, Swisher-McClure S, Mitra N, Li J, Cohen RB, Ahn PH, Lukens JN, Chalian AA, Weinstein GS, O’Malley BW Jr, Lin A. Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys. 2015;92:594–601.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Bidhu K. Mohanti
    • 1
  1. 1.Department of Radiation OncologyManipal HospitalNew DelhiIndia

Personalised recommendations